Subscribe To
Spero therapeutics to present data at the 33rd european congress of clinical microbiology and infectious diseases
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
April 14, 2023, 8:05 am
Why shares of inovio pharmaceuticals were down tuesday
Inovio said it has enough cash to fund operations into the first quarter of 2025. The company focuses on DNA medicines to treat HPV diseases, cancer, ...
April 4, 2023, 3:10 pm
Avricore health expands healthtab network to more than 530 locations and adds testing for virus detection
Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc, which is focused on delivering point-of-care testing and data solutions for pharmacies through its turnke...
March 23, 2023, 2:46 pm
Biondvax to present at bio-europe spring
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . (Nasdaq: BVXV), a biopharmaceutical company focused...
March 16, 2023, 1:10 pm
Scancell holdings had no exposure to silicon valley bank, company assures stakeholders
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), the developer of novel immunotherapies for treating cancer and in...
March 13, 2023, 3:38 am
Agenus to provide corporate update and fourth quarter & full year 2022 financial report
Conference Call on Tuesday, March 14, 2023 at 8:30 a.m. ET LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) — Agenus (Nasdaq: AGEN), an immuno-oncol...
February 28, 2023, 12:30 pm
Spanish authorities detect first suspected case of marburg disease
MADRID (Reuters) -Spain has detected its first suspected case of Marburg disease, a deadly infectious d...
February 25, 2023, 1:36 pm
Opgen announces exercise of all prefunded warrants
ROCKVILLE, Md., Feb. 17, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...
February 17, 2023, 12:30 pm
Valo therapeutics secures eur 2.23 million from the european innovation council to progress innovative peptichip technology
HELSINKI, Finland, Feb. 14, 2023 (GLOBE NEWSWIRE) — Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer and ...
February 14, 2023, 8:29 am
Aethlon medical to release third quarter financial results and host conference call on february 13, 2023
SAN DIEGO , Feb. 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a company developing medical therapeutics to treat cancer and life-thre...
February 6, 2023, 8:01 am
Biondvax presenting at bio ceo & investor conference
JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd . ( Nasdaq: BVXV ), a biotechnology company focused on ...
February 2, 2023, 2:15 pm
Tonix pharmaceuticals announces publication of paper in antiviral research highlighting the company’s development of monoclonal antibody therapeutics for monkeypox and smallpox
Data Represent Research and Development Work Being Conducted at Tonix’s infectious Disease R&D Center...
January 24, 2023, 12:00 pm
Vir biotechnology: high potential returns with high volatility risks
Vir Biotechnology is a commercial-stage immunology company that bases its activity on infectious diseas...
January 19, 2023, 2:59 am
Opgen subsidiary curetis meets several key milestones in find collaboration project
Successful delivery of milestones triggers milestone payment ROCKVILLE, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”...
January 17, 2023, 12:30 pm
Opgen announces closing of $7.5 million public offering
ROCKVILLE, Md., Jan. 11, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...
January 11, 2023, 9:30 pm
Veterinary surgical instruments market is anticipated to reach us$ 1.86 billion by 2033: fact.mr research
High Rate of Pet Adoption Worldwide and Increasing Cases of infectious Diseases Fuelling Sales of Veter...
January 11, 2023, 7:00 pm
In vitro diagnostics (ivd) quality control market is expected to reach around usd 71.43 billion in 2022, grow at a cagr of 6.0% during forecast period 2023 to 2030 | data by contrive datum insights pv
Farmington, Jan. 10, 2023 (GLOBE NEWSWIRE) — The Global In Vitro Diagnostics (IVD) Quality Control Market is projected to grow from USD 71.43 Billio...
January 10, 2023, 5:55 pm
In vitro diagnostics (ivd) quality control market is expected to reach around usd 71.43 billion in 2022, grow at a cagr of 6.0% during forecast period 2023 to 2030 | data by contrive datum insights pv
Farmington, Jan. 10, 2023 (GLOBE NEWSWIRE) — The Global In Vitro Diagnostics (IVD) Quality Control Market is projected to grow from USD 71.43 Billio...
January 10, 2023, 5:55 pm
Molecular partners provides updates at 41st annual jpm healthcare conference
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR : Molecular Partners A...
January 8, 2023, 8:00 pm
Opgen announces pricing of $7.5 million public offering
ROCKVILLE, Md., Jan. 06, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessi...
January 7, 2023, 1:00 am